Trial Profile
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2023
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Alcoholism; Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 01 Aug 2023 Status changed from recruiting to completed.
- 14 Feb 2023 Planned End Date changed from 31 Dec 2022 to 31 Dec 2023.
- 14 Feb 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.